Welcome to STAR-LIFE registry!
This study is an observational, multicentric registry focused on data collection after MINIject® implantation in a real-life setting. Adult patients diagnosed with open angle glaucoma and treated with MINIject® are followed for 2 years according to standard of care.
The objective of this registry is to collect real-world evidence on:
- The usability of MINIject®
- Patient reported outcomes such as quality of life
- Device safety over a period of 2 years after implantation
For any questions, please reach out to:
Florence Defresne - Clinical Project Lead
Céline Desmet - In-house Clinical Research Associate